CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Net Cash Flow (2013 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly Net Cash Flow came in at -$2667.0 in Q2 2026, up 91.67% YoY from -$1391.4 in Q2 2025, and down 159.92% on a QoQ basis from $4451.0 in Q1 2026.

CNBX Pharmaceuticals Inc. (CNBX) Net Cash Flow (2013 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 14 years of Net Cash Flow data on file, last reported at -$2667.0 in Q2 2026.

  • Quarterly Net Cash Flow rose 91.67% year-over-year to -$2667.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$4161.0 (up 93.04% YoY) and the FY2025 annual result came in at -$11305.0, up 89.05% from the prior year.
  • Net Cash Flow slipped to -$2667.0 in Q2 2026, from $4451.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $96157.0 in Q2 2024 to a low of -$554777.0 in Q1 2022.
  • A 5-year average of -$42893.1 and a median of -$5502.5 in 2023 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 2773.26% in 2024, down 499.26% in 2024.
  • Tracing CNBX's Net Cash Flow over 5 years: stood at -$95915.0 in 2022, then soared by 49.9% to -$48049.0 in 2023, then surged by 81.11% to -$9077.0 in 2024, then climbed by 18.39% to -$7408.0 in 2025, then surged by 64.0% to -$2667.0 in 2026.
  • The last three Net Cash Flow figures came in at -$2667.0 (Q2 2026), $4451.0 (Q1 2026), and -$7408.0 (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
May 31, 2026 -2,667.00
May 31, 2026 -2,667.00
Feb 28, 2026 4,451.00
Feb 28, 2026 4,451.00
Nov 30, 2025 -7,408.00
Nov 30, 2025 -7,408.00
Aug 31, 2025 1,463.00
Aug 31, 2025 1,463.00
May 31, 2025 -32,027.00
May 31, 2025 -32,027.00
Feb 28, 2025 28,336.00
Feb 28, 2025 28,336.00
Nov 30, 2024 -9,077.00
Nov 30, 2024 -9,077.00
Aug 31, 2024 -46,990.00
Aug 31, 2024 -46,990.00
May 31, 2024 96,157.00
May 31, 2024 96,157.00
Feb 29, 2024 -104,398.00
Feb 29, 2024 -104,398.00